CALYPTE BIOMEDICAL CORP Repayments of Notes Payable
CALYPTE BIOMEDICAL CORP reported Repayments of Notes Payable of $28.00 thousand for the 12-month period ending 2012-12-31, per its 10-K filed 2014-06-24.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfNotesPayable · last filed 2014-06-24
- CALYPTE BIOMEDICAL CORP repayments of notes payable for the quarter ending 2012-12-31 was $7.00K, a 133.33% increase year-over-year.
- CALYPTE BIOMEDICAL CORP repayments of notes payable for the quarter ending 2012-09-30 was $7.00K.
- CALYPTE BIOMEDICAL CORP repayments of notes payable for the quarter ending 2011-12-31 was $3.00K, a 88.89% decline year-over-year.
- CALYPTE BIOMEDICAL CORP repayments of notes payable for the quarter ending 2011-09-30 was $0.00.
- CALYPTE BIOMEDICAL CORP repayments of notes payable for fiscal 2012 was $28.00K, a 55.56% increase from fiscal 2011.
- CALYPTE BIOMEDICAL CORP repayments of notes payable for fiscal 2011 was $18.00K, a 58.14% decline from fiscal 2010.
- CALYPTE BIOMEDICAL CORP repayments of notes payable for fiscal 2010 was $43.00K.
| Period end | Repayments of Notes Payable 3 month | Repayments of Notes Payable 6 month | Repayments of Notes Payable 9 month | Repayments of Notes Payable 12 month |
|---|---|---|---|---|
| 2012-12-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-06-24 | $14.00K derived: sum of 2 quarters · filed 2014-06-24 | $28.00K 10-K · filed 2014-06-24 | |
| 2012-09-30 | $7.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-12-31 | $21.00K 10-Q · filed 2012-12-31 | ||
| 2012-06-30 | $14.00K 10-Q · filed 2012-08-14 | |||
| 2011-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-06-24 | $3.00K derived: sum of 2 quarters · filed 2014-06-24 | $18.00K 10-K · filed 2014-06-24 | |
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-12-31 | $15.00K 10-Q · filed 2012-12-31 | ||
| 2011-06-30 | $15.00K 10-Q · filed 2012-08-14 | |||
| 2010-12-31 | $27.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-22 | $27.00K derived: sum of 2 quarters · filed 2012-03-22 | $43.00K 10-K · filed 2012-03-22 | |
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-01-27 | $16.00K 10-Q · filed 2012-01-27 | ||
| 2010-06-30 | $16.00K 10-Q/A · filed 2011-11-30 |